FDA Investigator Milos Dokmanovic, PhD
Milos Dokmanovic, PhD has inspections in 3 countries as of 11 Oct 2023. Milos Dokmanovic, PhD has collaborated with a combined 2334 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
11 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Germany,
Ireland
Co-Investigator(s):
Amir Alavi,
Andrew J Barrowcliff,
Anh M Lac,
Anita Narula, PhD,
Ann L Demarco,
Arulvathani P Arudchandran,
Ashar P Parikh,
Azza Talaat,
Bo Chi, PhD,
Brenda W Uratani, PhD,
Candace Y Gomez Broughton,
Carl A Huffman, III,
Carl Lee,
Carolyn A Renshaw,
CDR Ileana Barreto Pettit,
CDR Rochelle B Young, RPh, MSA,
Charisse K Green,
Christopher Downey, PhD,
David G Eng,
Dennis Cantellops Paite,
Diane L Raccasi,
Doan T Nguyen, PharmD,
Donald C Obenhuber, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Robert C Horan, MD,
Eliezar Ramos,
Erika V Butler,
Erin D Mccaffery,
Felix Maldonado,
Francis A Guidry,
Guerlain Ulysse,
Henry K Lau,
J Paul Kirwan, PhD,
Jacqueline Mdiaz Albertini,
James R Evans,
Javier E Santos,
Jay T Wong,
Jeffrey M Watson,
Jens Fricke,
Jing Fang,
John D White,
Joseph Kutze, PhD,
Julie D Bringger,
Junho Pak,
Kalavati Suvarna, PhD,
Kathleen R Jones, PhD,
Kathryn E King,
Keith O Webber, PhD,
Keith Webber, PhD,
Kevin A Gonzalez,
Kouros Kangarli,
Kshitij A Patkar,
Kurt A Brorson, PhD,
Lakshmi Narasimhan, PhD,
Lance M De Souza, MBA,
Laura Fontan, MS,
Laurie Graham,
LCDR Chad N Thompson,
Linan Ha, PhD,
Lucila B Nwatu,
Margaret E Sarles,
Maria Cecilia Tami, PhD,
Maria G Gutierrez Hoffman,
Maria Joselopez Barragan, PhD,
Mariza M Jafary,
Mark Brunswick, PhD,
Marshalette Edwards,
Marshalette O Edwards,
Mary E Storch,
Maxwell Van Tassell, PhD,
Michael Shanks, MS,
Michelle Rfrazier Jessen, PhD,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mindy M Chou,
Monica Commerford, PhD,
Mra Davism,
Mra Munizn,
Natalia Pripuzova, PhD,
Nicholas L Hunt,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Patrick C Klotzbuecher,
Paul Mouris,
Peter E Baker,
Prabhu P Raju,
Qing Joanna Zhou, PhD,
Rajiv R Srivastava,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Richard W Berning,
Robert D Tollefsen,
Robert J Martin,
Robert W Jennings,
Rose M Ashley,
Ruth Moore, PhD,
Sarah Kennett, PhD,
Scott N Lim,
Sharon K Thoma, PharmD,
Shirley J Berryman,
Sidney B Priesmeyer,
Sony Mathews,
Stephanie A Slater, MS,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tzanko Stantchev,
Uttaniti Limchumroon (Tom),
Veronica Fuentes, MS,
Virgilio F Pacio, CSO,
Walter N Lange,
Wayne E Seifert,
William V Millar,
Willie Wilson,
Xu Michael Di, PhD,
Yanming An, PhD,
Yun Wu, PhD,
Zerita White,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD,
Ziyang Su, PhD
Milos Dokmanovic, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2019 | EIR | Regeneron Pharmaceuticals, Inc. - EIR, 2019-11-08 |
March, 2018 | FDA 483 | Eli Lilly Kinsale Limited - Form 483, 2018-03-16 |
September, 2018 | FDA 483 | Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483, 2018-09-21 |
August, 2016 | FDA 483 | Genentech, Inc. - Form 483, 2016-08-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more